A clinical cassette microdose study of aromatase inhibitors
- Conditions
- The breast cancer metastasized to the brain
- Registration Number
- JPRN-UMIN000007025
- Lead Sponsor
- Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 6
Not provided
1) Volunteers who have present and/or past history of disease of heart and circulatory system, liver, kidney and ureteral system, digestive system, and blood system 2) Volunteers who have present and/or past history of drug and alcohol addiction and drug allergy 3) Volunteers who is taking medicines which will affect the result of this study 4) Volunteers who had any medicines within 7 days before taking study drugs 5) Volunteers who takes health food product like St.John's wort and/or fruit juice including grape fruit juice within 7 days before taking study drugs 6) Volunteers who joined other clinical study within 3 months before this study 7) Volunteers who donated blood before this study such as: (a) >200 mL within a month (b) >400 mL within 3 months 8) Volunteers who is positive for serological reaction of syphilis, HIV antibody, HBs antigen, HCV antibody 9) Others: Volunteers who are diagnosed by medical doctors as unsuitable for joining this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma pharmacokinetics of Cetrozole, TMD-322 and anastrozole
- Secondary Outcome Measures
Name Time Method Safety